The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantitative CT lung fibrosis and immune checkpoint inhibitor–related pneumonitis in NSCLC.
 
Mitchell Boshkos
No Relationships to Disclose
 
Amgad Muneer
No Relationships to Disclose
 
Eman Showkatian
No Relationships to Disclose
 
Felipe Soto
No Relationships to Disclose
 
Ferando Camacho
No Relationships to Disclose
 
Gregory Gaskey
No Relationships to Disclose
 
Mazen Aiche
No Relationships to Disclose
 
Sarah Forsythe
No Relationships to Disclose
 
Karthik Suresh
No Relationships to Disclose
 
Rupali Sood
No Relationships to Disclose
 
Mohammad Ghanbar
No Relationships to Disclose
 
Samuel Peterson
No Relationships to Disclose
 
Joshua Schirm
No Relationships to Disclose
 
Kevin Ho
No Relationships to Disclose
 
Girish Shroff
No Relationships to Disclose
 
Aung Naing
Employment - Baylor College of Medicine and Texas Children's Hospital (I); MD Anderson Cancer Center
Honoraria - AKH Inc.; American Society of Clinical Oncology; CME Outfitters; ESMO; Korean Society of Medical Oncology (KSMO); Lynx Group; Scripps Hospital; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Abbvie; Cogent Biosciences (I); CTI; CytomX Therapeutics; Deka Biosciences; Genome & Company; Immune-Onc Therapeutics; Janssen Biotech; Lynx Health; Merk Sharp & Dohme Corp; NGM Biopharmaceuticals; Nouscom; OncoSec; Pharming NV (I); PsiOxus Therapeutics; SERVIER; STCube Pharmaceuticals Inc.; The Immune Deficiency Foundation (I)
Speakers' Bureau - WebMD (I)
Research Funding - Amplimmune; Arcus Biosciences; ARMO BioSciences; Atterocor; BioNTech SE; Bristol-Myers Squibb; Calithera Biosciences; CytomX Therapeutics; EMD Serono; GV 20 Therapeutics; Healios; Immune Deficiency Foundation (I); Immune-Onc Therapeutics; Incyte; Jeffrey Modell Foundation (I); Karyopharm Therapeutics; Kymab; Lilly; MedImmune; Merck; Monopteros Therapeutics; NCI; NeoImmuneTech; Neon Therapeutics; Novartis; Pfizer; PsiOxus Therapeutics; Regeneron; Seven and Eight Biopharmaceuticals; Sotio; Surface Oncology; Takeda (I); TopAlliance BioSciences Inc
Travel, Accommodations, Expenses - ARMO BioSciences; NeoImmuneTech; NGM Biopharmaceuticals
Other Relationship - Pharming-PI for clinical trial (I)
(OPTIONAL) Uncompensated Relationships - KN Foundation USA
 
Saadia Faiz
No Relationships to Disclose
 
Jia Wu
No Relationships to Disclose
 
Mehmet Altan
Consulting or Advisory Role - AstraZeneca; BMS; GlaxoSmithKline; InSightec; Lyell Immunopharma; Regeneron
Speakers' Bureau - Nektar
Research Funding - Adaptimmune (Inst); BioNTech SE; Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Henlius; Jounce Therapeutics (Inst); Lilly (Inst); Lyell Immunopharma (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer; Shattuck Labs (Inst); verismo (Inst)
Travel, Accommodations, Expenses - Nektar
Other Relationship - Hengenix; Nanobiotix (Inst)
 
Ajay Sheshadri
No Relationships to Disclose